GlassScriptPhysician profile
Abraham N Katz
NPI 1275951774
$4,088.60
in general payments reported to CMS, 2019-2025
8 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,822 · 2023: $258 · 2024: $1,624 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,507 · Travel and Lodging: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.95 |
| Travel and Lodging | $759.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,336.43 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bolton Medical INC | $419.22 | 2023-2025 | Treo Abdominal Stent-Graft System, Gelweave |
| Abiomed | $125.08 | 2024-2025 | Impella |
| Atricure, INC. | $71.34 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| W. L. Gore & Associates, INC. | $56.06 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Abbott Laboratories | $34.65 | 2024 | Mitraclip |
| Cvrx, INC. | $28.59 | 2025 | Barostim Neo System |
| Medtronic, INC. | $17.23 | 2024 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.